Orthofix Launches Opus Bone Void Filler

Opus Mg Set is a magnesium-based settable bone void filler for orthopedic procedures.

Anika’s Tactoset Injectable Bone Substitute Now FDA-Cleared for Hardware Augmentation

The injectable bone substitute is now FDA 510(k) cleared for augmenting suture anchor fixation.

Kuros Biosciences Gains FDA 510(k) Clearance for MagnetOs Easypack Putty

The clearance follows existing clearances by the FDA for the use of MagnetOs Granules and MagnetOs Putty in the spine.

Royal Biologics Gains FDA 510(k) for Maxx Concentration System

Maxx-PRP is a next-gen device to concentrate autologous whole blood for the safe and rapid preparation of platelet-rich plasma.

Study Update: OssDsign Synthetic Bone Graft

The first patient has been treated in a study to investigate OssDsign Catalyst in patients undergoing spinal fusion.

Locate Bio Closes £10 Million Funding Round

Proceeds will further advance the company's regenerative medicine pipeline of orthobiologic products.

Study Results: Bone Therapeutics’ Viscosupplement for Knee OA

The Phase III study with JTA-004 viscosupplement did not meet the primary and consequently the key secondary endpoints.

Study Results: Cerapedics’ i-FACTOR vs. Local Autologous Bone in ACDF

Published data show that i-FACTOR is not only cost-effective compared to autograft in ACDF, but is the dominant economic strategy.

Royal Biologics Partners with Vilex for Lower Extremities

Vilex will market and distribute Royal Biologics' portfolio of Autologous and Live Cellular therapies for lower extremity orthopedic procedures.

OssDsign Launches Catalyst Synthetic Bone Graft

OssDsign Catalyst is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries.

Royal Biologics Partners with Vilex for Lower Extremities

Vilex will market and distribute Royal Biologics' portfolio of Autologous and Live Cellular therapies for lower extremity orthopedic procedures.

The merger will create a company positioned with products and specialized salesforces serving hospital, ambulatory surgical center and office care settings.

Exactech and RTI Surgical Enter Strategic Partnership

Exactech's Optecure demineralized bone matrix will complement RTI Surgical's portfolio of bone graft substitutes.

Orthofix Launches Opus Bone Void Filler

Opus Mg Set is a magnesium-based settable bone void filler for orthopedic procedures.

The first patient has been treated in a study to investigate OssDsign Catalyst in patients undergoing spinal fusion.

Proceeds will further advance the company's regenerative medicine pipeline of orthobiologic products.

Anika’s Tactoset Injectable Bone Substitute Now FDA-Cleared for Hardware Augmentation

The injectable bone substitute is now FDA 510(k) cleared for augmenting suture anchor fixation.

The clearance follows existing clearances by the FDA for the use of MagnetOs Granules and MagnetOs Putty in the spine.

Maxx-PRP is a next-gen device to concentrate autologous whole blood for the safe and rapid preparation of platelet-rich plasma.

Orthofix Launches Opus Bone Void Filler

Anika’s Tactoset Injectable Bone Substitute Now FDA-Cleared for Hardware Augmentation

Kuros Biosciences Gains FDA 510(k) Clearance for MagnetOs Easypack Putty

Royal Biologics Gains FDA 510(k) for Maxx Concentration System

Study Update: OssDsign Synthetic Bone Graft

Locate Bio Closes £10 Million Funding Round

Study Results: Bone Therapeutics’ Viscosupplement for Knee OA

Study Results: Cerapedics’ i-FACTOR vs. Local Autologous Bone in ACDF

Royal Biologics Partners with Vilex for Lower Extremities

OssDsign Launches Catalyst Synthetic Bone Graft

M&A | Partnerships

Royal Biologics Partners with Vilex for Lower Extremities

Bioventus to Acquire Misonix, Enhance Surgical Solutions

Exactech and RTI Surgical Enter Strategic Partnership

Products

Orthofix Launches Opus Bone Void Filler

Study Update: OssDsign Synthetic Bone Graft

Locate Bio Closes £10 Million Funding Round

Regulatory

Anika’s Tactoset Injectable Bone Substitute Now FDA-Cleared for Hardware Augmentation

Kuros Biosciences Gains FDA 510(k) Clearance for MagnetOs Easypack Putty

Royal Biologics Gains FDA 510(k) for Maxx Concentration System